drugset / Trial / NCT04654065

Study to Evaluate Oral Mucosa Absorption of IN-C004 in Healthy Volunteers

NCT04654065 ↗

Phase 1 Completed 6 enrolled HK inno.N Corporation
NaSingle-groupOpen-labelOther

Summary

To evaluate whether IN-C004 absorbs oral mucosa in healthy volunteers.

Timeline

Start
2021-01-04
Primary completion
2021-01-05
Completion
2021-01-05

Drugs

EvaluationDrugModalityDoseRoute
Subject IN-C004 Unknown — Oral

Indications

No indication recorded.